.jpg?format=webp&width=780)
The use of aspirin as thromboprophylaxis to prevent venous thromboembolism after hip or knee replacement surgery is included in clinical guidelines, but its use in patients with extremity fractures is still debated due to limited data. The PREVENT CLOT trial conducted by the METRC tested the noninferiority of aspirin compared to low-molecular-weight heparin for thromboprophylaxis in patients with extremity fractures.
Like
Save
Share